<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Interacting With the Food and Drug Administration on Complex Innovative Trial Designs for Drugs and Biological Products; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Interacting With the Food and Drug Administration on Complex Innovative Trial Designs for Drugs and Biological Products; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2020-12-17 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products." The guidance provides recommendations to sponsors and applicants on interacting with FDA on complex innovative trial design (CID) proposals for drugs or biological products. FDA is issuing this guidance to satisfy, in part, a mandate under the 21st Century Cures Act (Cures Act). In accordance...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-27813</p>
    <p><strong>Publication Date:</strong> 2020-12-17</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/12/17/2020-27813/interacting-with-the-food-and-drug-administration-on-complex-innovative-trial-designs-for-drugs-and">https://www.federalregister.gov/documents/2020/12/17/2020-27813/interacting-with-the-food-and-drug-administration-on-complex-innovative-trial-designs-for-drugs-and</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-27813</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
